CHF128.20
1.42% today
SIX Swiss Exchange, Apr 01, 05:30 pm CET
ISIN
CH0468525222
Symbol
MOVE
Sector

Medacta Stock price

CHF128.20
-5.40 4.04% 1M
+5.80 4.74% 6M
+21.60 20.26% YTD
+5.80 4.74% 1Y
+18.20 16.55% 3Y
+76.10 146.07% 5Y
+32.10 33.40% 10Y
SIX Swiss Exchange, Closing price Tue, Apr 01 2025
+1.80 1.42%
ISIN
CH0468525222
Symbol
MOVE
Sector

Key metrics

Market capitalization CHF2.52b
Enterprise Value CHF2.72b
P/E (TTM) P/E ratio 36.25
EV/FCF (TTM) EV/FCF 161.06
EV/Sales (TTM) EV/Sales 4.83
P/S ratio (TTM) P/S ratio 4.48
P/B ratio (TTM) P/B ratio 7.07
Dividend yield 0.55%
Last dividend (FY24) CHF0.69
Revenue growth (TTM) Revenue growth 13.35%
Revenue (TTM) Revenue CHF562.53m
EBIT (operating result TTM) EBIT CHF89.89m
Free Cash Flow (TTM) Free Cash Flow CHF16.87m
EPS (TTM) EPS CHF3.49
P/E forward 30.11
P/S forward 3.93
EV/Sales forward 4.24
Show more

Is Medacta a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Medacta Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Medacta forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Medacta forecast:

Buy
86%
Hold
14%

Financial data from Medacta

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
563 563
13% 13%
100%
- Direct Costs 182 182
15% 15%
32%
381 381
13% 13%
68%
- Selling and Administrative Expenses 208 208
10% 10%
37%
- Research and Development Expense 20 20
6% 6%
4%
152 152
17% 17%
27%
- Depreciation and Amortization 62 62
9% 9%
11%
EBIT (Operating Income) EBIT 90 90
23% 23%
16%
Net Profit 69 69
50% 50%
12%

In millions CHF.

Don't miss a Thing! We will send you all news about Medacta directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The firm offers personalized kinematic models and three-dimensional planning tools for use in hip, knee, shoulder, and spine procedures. It operates through the following geographical segments: Europe, North America, Asia Pacific, and Rest of the World. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.

Head office Switzerland
CEO Francesco Siccardi
Employees 1,907
Founded 1999
Website www.medacta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today